EUVIMEDEUVIMED entdecken
Crossref

Engineered Bacterial Biosynthesis of a Cysteine-Rich SPRR2A Fusion Protein with Dual Antibacterial and Anticancer Efficacy

Pinlong He, Hongrui Liu, Junyi Yuan, Hui Gao, Bin-Chun Li iD, Roland H Stauber, Bozhao Li, Guo-Bin Ding iD

ACS Synthetic Biology · 2026

DOI: 10.1021/acssynbio.6c00021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, 2026. Verfasst von Pinlong He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institutes of Biomedical Sciences, Inner Mongolia University, Hohhot 010070, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Anti-Bacterial Agents, Recombinant Fusion Proteins, Escherichia coli. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation Project of Inner Mongolia Autonomous Region, Inner Mongolia Autonomous Region Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial peptides represent promising candidates for anticancer therapy, owing to their membrane-disrupting mechanisms. Small proline-rich protein 2A (SPRR2A), a cysteine-rich gut bactericidal peptide, exhibits potent activity against Gram-positive bacteria via membrane integrity disruption. However, its complex disulfide bond network has hindered the production of bioactive SPRR2A in prokaryotic systems. Herein, we report an efficient prokaryotic biosynthesis strategy for a bioactive SPRR2A fusion protein, Trx-SPRR2A, leveraging an Escherichia coli Rosetta-gami (DE3) pLysS strain. The recombinant Trx-SPRR2A, obtained with a high yield (7.18 mg/L) and purity (94.5%), correctly formed five intrachain disulfide bonds and demonstrated remarkable thermal and serum stability. Functionally, Trx-SPRR2A displayed dose-dependent antibacterial activity with high selectivity toward Gram-positive bacteria. Notably, it exhibited selective cytotoxicity against MCF-7 breast cancer cells under weakly acidic conditions, a hallmark of the tumor microenvironment. Mechanistic studies revealed that the dual functionality stems from membrane disruption in both bacterial and cancer cells alongside the induction of apoptosis in MCF-7 cells. This work not only provides a robust method for producing complex disulfide-rich peptides but also highlights Trx-SPRR2A as a compelling dual-function therapeutic agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAnti-Bacterial AgentsRecombinant Fusion ProteinsEscherichia coliAntimicrobial PeptidesHumansMCF-7 CellsCysteineApoptosisGram-Positive BacteriaDisulfidesMicrobial Sensitivity Tests

Stichwörter der Autor:innen

SPRR2Aantibacterialantitumorbacterial biosynthesisdisulfide bondsmembrane disruption

Substanzen

Antineoplastic AgentsAnti-Bacterial AgentsRecombinant Fusion ProteinsCysteineAntimicrobial PeptidesDisulfides

Autor:innen und Institutionen

  • Institutes of Biomedical Sciences, Inner Mongolia University, Hohhot 010070, China.
  • Institute of Biotechnology, Shanxi University, Taiyuan 030006, China.
  • Inner Mongolia Key Laboratory for Molecular Regulation of the Cell, School of Life Sciences, Inner Mongolia University, Hohhot 010070, China.
  • Nanobiomedicine Department/ENT, University Medical Center Mainz, Mainz 55131, Germany.

ORCID-Profile: Bin-Chun Li, Guo-Bin Ding

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation Project of Inner Mongolia Autonomous Region
  • Inner Mongolia Autonomous Region Science and Technology Plan Project
  • Central Guiding Local Science and Technology Development Fund

Zitieren

APA

He, P., Liu, H., Yuan, J., Gao, H., Li, B. C., Stauber, R. H., Li, B., & Ding, G. B. (2026). Engineered Bacterial Biosynthesis of a Cysteine-Rich SPRR2A Fusion Protein with Dual Antibacterial and Anticancer Efficacy. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.6c00021

Vancouver

He P, Liu H, Yuan J, Gao H, Li BC, Stauber RH, et al. Engineered Bacterial Biosynthesis of a Cysteine-Rich SPRR2A Fusion Protein with Dual Antibacterial and Anticancer Efficacy. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.6c00021

BibTeX
@article{He2026,
  author = {He, Pinlong and Liu, Hongrui and Yuan, Junyi and Gao, Hui and Li, Bin-Chun and Stauber, Roland H and Li, Bozhao and Ding, Guo-Bin},
  title = {Engineered Bacterial Biosynthesis of a Cysteine-Rich SPRR2A Fusion Protein with Dual Antibacterial and Anticancer Efficacy},
  journal = {ACS Synthetic Biology},
  year = {2026},
  doi = {10.1021/acssynbio.6c00021}
}
Kostenlos starten →